Cardiac troponin T elevation predicts mortality in hospitalized COVID-19 patients
Katelyn A Bruno1,2, R Scott Wright3, Joshua Culberson1,2
1Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, United States of America.
Insights
High-sensitivity cardiac troponin T (hs-cTnT) levels predict mortality in hospitalized COVID-19 patients. This prognostic ability holds true for both males and females, irrespective of age.
Area of Science:
- Cardiology
- Infectious Diseases
- Biomarkers
Background:
- COVID-19 can cause cardiac injury, impacting patient outcomes.
- Cardiac troponins are key biomarkers for myocardial damage.
Purpose of the Study:
- To determine if cardiac troponin T (hs-cTnT) levels predict mortality in hospitalized COVID-19 patients.
- To assess this prognostic ability across diverse demographics including sex and age.
Main Methods:
- Analysis of hs-cTnT levels in 1050 severely ill COVID-19 patients.
- Data collected during the first wave of the pandemic (April-August 2020).
- Inclusion of patients from the Expanded Access Program for convalescent plasma study.
Main Results:
- A continuous relationship was observed between hs-cTnT levels and mortality.
- This association was consistent across both male and female patients.
- The prognostic value of hs-cTnT was independent of patient age.
Conclusions:
- hs-cTnT is a valuable prognostic biomarker for predicting mortality in hospitalized COVID-19 patients.
- The predictive capability of hs-cTnT extends across all relevant patient groups.
- Clinical Trials registration number: NCT04338360.
Objective:
To evaluate if cardiac troponin values predict poor outcomes in COVID-19 patients across the range of patients of different sex and age.
Methods:
We examined high-sensitivity cardiac troponin T (hs-cTnT) levels in 1050 severely ill hospitalized COVID-19 patients who had hs-cTnT data available and participated in the Expanded Access Program for convalescent plasma study during the first wave (April-August 2020) of the COVID-19 pandemic.
Results:
We observed a continuous relationship between hs-cTnT levels and mortality in hospitalized males and females with COVID-19. This finding was present regardless of sex or age.
Conclusion:
These data indicate the prognostic ability of hs-cTnT to predict mortality in hospitalized COVID-19 patients across all relevant patient groups.Clinical Trials registration number: NCT04338360.
More Related Videos
07:40Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
Published on: October 10, 2019
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Myocarditis III: Medical Management
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis II: Clinical Features and Diagnostic Tests
